Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders

Neurology

Volumn 76, Issue 11, 2011, Pages 960-967

  Finanger Hedderick, E L ^a   Simmers, J L ^b   Soleimani, A ^b   Andres Mateos, E ^b   Marx, R ^b   Files, D C ^c   King, L ^c   Crawford, T O ^a   Corse, A M ^a   Cohn, R D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Division of Pulmonary and Critical Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATABOLISM; CHILD; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFANT; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE HYPOTONIA; MYOPATHY; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOLEMMA; STRESS;

EID: 79953181305     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31821043c8     Document Type: Article

References (22)

1. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001;81:209-237. (Pubitemid 32096176)
2. Silvagno F, Xia H, Bredt DS. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 1996;271: 11204-11208.
3. McAllister RM, Delp MD, Thayer KA, Laughlin MH. Muscle blood flow during exercise in sedentary and trained hypothyroid rats. Am J Physiol 1995;269:H1949-1954. (Pubitemid 26023210)
4. Thomas GD, Shaul PW, Yuhanna IS, Froehner SC, Adams ME. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal nitric oxide synthase. Circ Res 2003;92:554-560. (Pubitemid 36368669)
5. Wadley GD, Choate J, McConell GK. NOS isoformspecific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle. J Physiol 2007;585:253-262. (Pubitemid 350131117)
6. Roberts CK, Barnard RJ, Scheck SH, Balon TW. Exercisestimulated glucose transport in skeletal muscle is nitric oxide dependent. Am J Physiol 1997;273:E220-225.
7. Ross RM, Wadley GD, Clark MG, Rattigan S, McConell GK. Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats. Diabetes 2007;56:2885-2892. (Pubitemid 350223622)
8. Wehling-Henricks M, Oltmann M, Rinaldi C, Myung KH, Tidball JG. Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 2009; 18:3439-3451.
9. Suzuki N, Motohashi N, Uezumi A, et al. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 2007;117:2468-2476. (Pubitemid 47494348)
10. Pietri-Rouxel F, Gentil C, Vassilopoulos S, et al. DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis. EMBO J 2010;29:643-654.
11. Kobayashi YM, Rader EP, Crawford RW, et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008;456:511-515. (Pubitemid 352759004)
12. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;82:743-752.
13. Brenman JE, Chao DS, Gee SH, et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 1996;84:757-767. (Pubitemid 26094205)
14. Lai Y, Thomas GD, Yue Y, et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009;119: 624-635.
15. Crosbie RH, Barresi R, Campbell KP. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 2002;16: 1786-1791. (Pubitemid 35340359)
16. Suzuki N, Mizuno H, Warita H, Takeda S, Itoyama Y, Aoki M. Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis. J Neurol Sci 2010; 294:95-101.
17. Asai A, Sahani N, Kaneki M, Ouchi Y, Martyn JA, Yasuhara SE. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One 2007;2: e806.
18. Percival JM, Anderson KN, Huang P, Adams ME, Froehner SC. Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J Clin Invest 2010;120: 816-826.
19. Clementi E, Nisoli E. Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism. Comp Biochem Physiol A Mol Integr Physiol 2005; 142:102-110. (Pubitemid 41443568)
20. Reid MB. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand 1998;162:401-409. (Pubitemid 28121419)
21. Schild L, Jaroscakova I, Lendeckel U, Wolf G, Keilhoff G. Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism. FASEB J 2006;20:145-147. (Pubitemid 43100495)
22. Soraru G, Vergani L, Fedrizzi L, et al. Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. Neuropathol Appl Neurobiol 2007; 33:204-211. (Pubitemid 46385714)